JP2001522229A - 抗酸化剤タンパク質2、遺伝子及びそれらの使用方法 - Google Patents
抗酸化剤タンパク質2、遺伝子及びそれらの使用方法Info
- Publication number
- JP2001522229A JP2001522229A JP53515698A JP53515698A JP2001522229A JP 2001522229 A JP2001522229 A JP 2001522229A JP 53515698 A JP53515698 A JP 53515698A JP 53515698 A JP53515698 A JP 53515698A JP 2001522229 A JP2001522229 A JP 2001522229A
- Authority
- JP
- Japan
- Prior art keywords
- aop2
- polypeptide
- nucleic acid
- seq
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4089797P | 1997-04-02 | 1997-04-02 | |
US60/040,897 | 1997-04-02 | ||
PCT/US1998/006666 WO1998043666A1 (fr) | 1997-04-02 | 1998-04-01 | Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001522229A true JP2001522229A (ja) | 2001-11-13 |
Family
ID=21913589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53515698A Pending JP2001522229A (ja) | 1997-04-02 | 1998-04-01 | 抗酸化剤タンパク質2、遺伝子及びそれらの使用方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1005360A4 (fr) |
JP (1) | JP2001522229A (fr) |
CA (1) | CA2285631A1 (fr) |
WO (1) | WO1998043666A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006505290A (ja) * | 2002-11-10 | 2006-02-16 | インスティテュート オブ セル バイオフィジクス ロシアン アカデミー オブ サイエンシーズ | 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2798672B1 (fr) * | 1999-09-17 | 2003-10-31 | Commissariat Energie Atomique | Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic |
AUPR221300A0 (en) * | 2000-12-20 | 2001-01-25 | Malaysian Palm Oil Board | A molecular marker |
WO2012075911A1 (fr) * | 2010-12-06 | 2012-06-14 | Li Jianyuan | Utilisation d'une protéine prx-6 humaine recombinante dans le traitement d'une brûlure et d'un ébouillantage et/ou d'une lésion cornéenne |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2093008A1 (fr) * | 1990-10-01 | 1992-04-02 | Charles H. Hennekens | Utilisation therapeutique de beta-carotene et de vitamine e pour empecher les troubles vasculaires importants |
-
1998
- 1998-04-01 JP JP53515698A patent/JP2001522229A/ja active Pending
- 1998-04-01 CA CA002285631A patent/CA2285631A1/fr not_active Abandoned
- 1998-04-01 WO PCT/US1998/006666 patent/WO1998043666A1/fr not_active Application Discontinuation
- 1998-04-01 EP EP98919730A patent/EP1005360A4/fr not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006505290A (ja) * | 2002-11-10 | 2006-02-16 | インスティテュート オブ セル バイオフィジクス ロシアン アカデミー オブ サイエンシーズ | 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法 |
Also Published As
Publication number | Publication date |
---|---|
EP1005360A4 (fr) | 2001-02-07 |
EP1005360A1 (fr) | 2000-06-07 |
WO1998043666A1 (fr) | 1998-10-08 |
CA2285631A1 (fr) | 1998-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999038965A1 (fr) | Gene de la calvitie chez l'homme, proteine et utilisations associees | |
JP2001511002A (ja) | Ts10q23.3と称する腫瘍抑制因子 | |
JP2003501026A (ja) | 脂質代謝転写因子 | |
US20040010812A1 (en) | Human hyaluronan receptor | |
JP2001522229A (ja) | 抗酸化剤タンパク質2、遺伝子及びそれらの使用方法 | |
JP2001503631A (ja) | 緑内障に関連するタンパク質ならびに対応する核酸とそれらの治療および診断への利用 | |
JP2001514015A (ja) | Ts10q23.3と称する腫瘍抑制因子 | |
JP2003517812A (ja) | PrP様遺伝子 | |
JP2004502444A (ja) | 筋選択的カルシニューリン相互作用タンパク質(mcip)に関連する方法および組成物 | |
JP2002500623A (ja) | スプルーティタンパク質およびコーディング配列 | |
JP4651893B2 (ja) | 新規ポリペプチド、新規dna、新規抗体および新規遺伝子改変動物 | |
CA2314677A1 (fr) | Genes associes a l'asthme | |
US7718787B2 (en) | Gene families associated with cancers | |
JPH10327866A (ja) | ヘリカーゼをコードするヒトの遺伝子,cdc28−#3 | |
US20030054446A1 (en) | Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379 | |
JPH10146188A (ja) | ヒトのウェルナー症候群の原因遺伝子に対応するマウス遺伝子及び該遺伝子がコードするタンパク質 | |
US20020142417A1 (en) | Antioxidant protein 2, gene and methods of use therefor | |
JP2001517954A (ja) | Noey2遺伝子組成物およびその使用方法 | |
JP2004528822A (ja) | 筋特異的筋節カルシニューリン結合タンパク質(カルサルシン)に関する方法および組成物 | |
US20060234286A1 (en) | Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses | |
JPWO2002064770A1 (ja) | 新規スカベンジャー受容体クラスa蛋白質 | |
WO2001005803A1 (fr) | Nouveaux adnc associes a des nephropathies | |
US20060121471A1 (en) | Gene families associated with stomach cancer | |
WO2001098456A2 (fr) | Identification d'adnc associes a l'hyperplasie prostatique benigne | |
JP2005506042A (ja) | 細胞トランスポーターをコードするポリヌクレオチド、およびその使用方法 |